Wyden Statement on Trump Drug Pricing Executive Order
Washington, D.C. — Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement after the Trump Administration issued an executive order related to prescription drug pricing.
“Just like his first term, Trump is all bark and no bite when it comes to lowering the cost of prescription drugs,” Wyden said. “This executive order is rife with goodies that Big Pharma has been begging for, primarily by weakening Medicare negotiation, which is going to mean higher prices for American seniors and families while the drug companies get a windfall to the tune of $10 billion. Democrats created Medicare’s drug negotiation authority without a single Republican vote - now is the time for Trump to faithfully follow the law Congress passed without watering it down at Big Pharma’s request.”
###
Next Article Previous Article